{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:39:24Z","timestamp":1790768364068,"version":"4.1.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.14046","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:32:42Z","timestamp":1653478362000},"page":"e2214046","source":"Crossref","is-referenced-by-count":42,"title":["Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non\u2013Small Cell Lung Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Sanjay","family":"Popat","sequence":"first","affiliation":[{"name":"Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Liu","sequence":"additional","affiliation":[{"name":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Scheuer","sequence":"additional","affiliation":[{"name":"Roche Products Ltd, Welwyn Garden City, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alind","family":"Gupta","sequence":"additional","affiliation":[{"name":"Cytel, Inc, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace G.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Cytel, Inc, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreeram V.","family":"Ramagopalan","sequence":"additional","affiliation":[{"name":"Global Access, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Griesinger","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Pius-Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Subbiah","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"18","key":"zoi220412r2","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2217\/fon-2015-0055","article-title":"Impact of smoking on lung cancer treatment effectiveness: a review.","volume":"12","author":"Condoluci","year":"2016","journal-title":"Future Oncol"},{"key":"zoi220412r3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer.","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"3","key":"zoi220412r4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.annonc.2019.11.015","article-title":"Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non\u2013small-cell lung cancer and PD-L1 expression =50.","volume":"31","author":"Gainor","year":"2020","journal-title":"Ann Oncol"},{"key":"zoi220412r5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lungcan.2020.05.021","article-title":"Clinical and molecular correlates of tumor mutation burden in non\u2013small cell lung cancer.","volume":"146","author":"Sharpnack","year":"2020","journal-title":"Lung Cancer"},{"key":"zoi220412r6","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/OTT","article-title":"Impact of smoking on efficacy of PD-1\/PD-L1 inhibitors in non\u2013small cell lung cancer patients: a meta-analysis.","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"1","key":"zoi220412r7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12957-020-1792-4","article-title":"Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies: an up-to-date meta-analysis.","volume":"18","author":"Mo","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"5","key":"zoi220412r8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1634\/theoncologist.2018-0307","article-title":"Real-world outcomes of patients with metastatic non\u2013small cell lung cancer treated with programmed cell death protein 1 inhibitors in the year following US regulatory approval.","volume":"24","author":"Khozin","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"zoi220412r11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"11","key":"zoi220412r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34299","article-title":"Comparative effectiveness of atezolizumab, nivolumab, and docetaxel in patients with previously treated non\u2013small cell lung cancer.","volume":"4","author":"Ramagopalan","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi220412r13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40880-017-0187-6","article-title":"Proportion and clinical features of never-smokers with non\u2013small cell lung cancer.","volume":"36","author":"Cho","year":"2017","journal-title":"Chin J Cancer"},{"issue":"6","key":"zoi220412r14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/tca.v12.6","article-title":"Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: a case-control matched analysis from a large multicenter study.","volume":"12","author":"Cortellini","year":"2021","journal-title":"Thorac Cancer"},{"issue":"2","key":"zoi220412r15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/tca.v11.2","article-title":"Oncogene addiction and tumor mutational burden in non\u2013small-cell lung cancer: clinical significance and limitations.","volume":"11","author":"Smolle","year":"2020","journal-title":"Thorac Cancer"},{"key":"zoi220412r1","unstructured":"Centers for Disease Control and Prevention. What Are the Risk Factors for Lung Cancer? Accessed December 30, 2021. https:\/\/www.cdc.gov\/cancer\/lung\/basic_info\/risk_factors.htm"},{"key":"zoi220412r9","unstructured":"Birnbaum? B, Nussbaum? N, Seidl-Rathkopf? K, . Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research.? arXiv. Preprint posted online January 13, 2020. Accessed April 19, 2022. https:\/\/arxiv.org\/abs\/2001.09765"},{"key":"zoi220412r10","doi-asserted-by":"crossref","unstructured":"Ma? X, Long? L, Moon? S, . Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR.? medRxiv medRxiv. Preprint posted online May 30, 2020. Accessed May 6, 2022. doi:10.1101\/2020.03.16.20037143","DOI":"10.1101\/2020.03.16.20037143"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792672\/popat_2022_oi_220412_1652802128.23385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:32:47Z","timestamp":1653478367000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.14046","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}